Emma C. de Moel

Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors

Emma C. de Moel, Elisa A. Rozeman, Ellen Kapiteijn et al. · Cancer Immunology Research · 2018 · 189 citations · Full text

Immunology, Pathology, Immune System +16

In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response

Emma C. de Moel, V. Derksen, Leendert A. Trouw et al. · Arthritis Research & Therapy · 2019 · 57 citations · Full text

Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes

Emma C. de Moel, V. Derksen, Gerrie Stoeken et al. · Arthritis Research & Therapy · 2018 · 50 citations · Full text

Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis

Josephine A. M. P. Amkreutz, Emma C. de Moel, Lisa Theander et al. · Arthritis & Rheumatology · 2020 · 31 citations · Full text

Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs

Emma C. de Moel, Jürgen Rech, Michael Mähler et al. · Arthritis Research & Therapy · 2019 · 26 citations · Full text